Regen BioPharma Inc (RGBP)

[Musical Shares]

Time for Eli Lily to come over to RGBP and stop playing around.......

There is nothing to come around for. Eli knows this already.

No one in their right mind that works for a large pharma would pass up the opportunity to capitalize (or possibly capitalize) a new, alternative approach to small molecule druggability.

The PD-1 is an extracellular immune checkpoint. It has two working ligands.

NR2F6 is an intracellular immune checkpoint. It has no known ligand. That's why it is called an "Orphan."

Have to have a ligand to proceed.